Effects of side chain length of 10-methyl-aplog-1, a simplified analog of debromoaplysiatoxin, on PKC binding, anti-proliferative, and pro-inflammatory activities
© The Author(s) 2021. Published by Oxford University Press on behalf of Japan Society for Bioscience, Biotechnology, and Agrochemistry..
10-Methyl-aplog-1 (1), a simplified analog of debromoaplysiatoxin, exhibits a high binding affinity for protein kinase C (PKC) isozymes and potent antiproliferative activity against several cancer cells with few adverse effects. A recent study has suggested that its phenol group in the side chain is involved in hydrogen bonding and CH/π interactions with the binding cleft-forming loops in the PKCδ-C1B domain. To clarify the effects of the side chain length on these interactions, four analogs of 1 with various lengths of side chains (2-5) were prepared. The maximal PKC binding affinity and antiproliferative activity were observed in 1. Remarkably, the introduction of a bromine atom into the phenol group of 2 increased not only these activities but also proinflammatory activity. These results indicated that 1 has the optimal side chain length as an anticancer seed. This conclusion was supported by docking simulations of 1-5 to the PKCδ-C1B domain.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:85 |
---|---|
Enthalten in: |
Bioscience, biotechnology, and biochemistry - 85(2021), 1 vom: 07. Jan., Seite 168-180 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gonda, Atsuko [VerfasserIn] |
---|
Links: |
---|
Themen: |
52423-28-6 |
---|
Anmerkungen: |
Date Completed 23.06.2021 Date Revised 23.06.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/bbb/zbaa024 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321375173 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM321375173 | ||
003 | DE-627 | ||
005 | 20231225175655.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/bbb/zbaa024 |2 doi | |
028 | 5 | 2 | |a pubmed24n1071.xml |
035 | |a (DE-627)NLM321375173 | ||
035 | |a (NLM)33577665 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gonda, Atsuko |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effects of side chain length of 10-methyl-aplog-1, a simplified analog of debromoaplysiatoxin, on PKC binding, anti-proliferative, and pro-inflammatory activities |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.06.2021 | ||
500 | |a Date Revised 23.06.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2021. Published by Oxford University Press on behalf of Japan Society for Bioscience, Biotechnology, and Agrochemistry. | ||
520 | |a 10-Methyl-aplog-1 (1), a simplified analog of debromoaplysiatoxin, exhibits a high binding affinity for protein kinase C (PKC) isozymes and potent antiproliferative activity against several cancer cells with few adverse effects. A recent study has suggested that its phenol group in the side chain is involved in hydrogen bonding and CH/π interactions with the binding cleft-forming loops in the PKCδ-C1B domain. To clarify the effects of the side chain length on these interactions, four analogs of 1 with various lengths of side chains (2-5) were prepared. The maximal PKC binding affinity and antiproliferative activity were observed in 1. Remarkably, the introduction of a bromine atom into the phenol group of 2 increased not only these activities but also proinflammatory activity. These results indicated that 1 has the optimal side chain length as an anticancer seed. This conclusion was supported by docking simulations of 1-5 to the PKCδ-C1B domain | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a antiproliferative | |
650 | 4 | |a cancer | |
650 | 4 | |a debromoaplysiatoxin | |
650 | 4 | |a protein kinase C | |
650 | 4 | |a tumor promoter | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Lyngbya Toxins |2 NLM | |
650 | 7 | |a debromoaplysiatoxin |2 NLM | |
650 | 7 | |a 52423-28-6 |2 NLM | |
650 | 7 | |a Protein Kinase C-delta |2 NLM | |
650 | 7 | |a EC 2.7.11.13 |2 NLM | |
700 | 1 | |a Takada, Koji |e verfasserin |4 aut | |
700 | 1 | |a Yanagita, Ryo C |e verfasserin |4 aut | |
700 | 1 | |a Dan, Shingo |e verfasserin |4 aut | |
700 | 1 | |a Irie, Kazuhiro |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bioscience, biotechnology, and biochemistry |d 1992 |g 85(2021), 1 vom: 07. Jan., Seite 168-180 |w (DE-627)NLM012623830 |x 1347-6947 |7 nnns |
773 | 1 | 8 | |g volume:85 |g year:2021 |g number:1 |g day:07 |g month:01 |g pages:168-180 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/bbb/zbaa024 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 85 |j 2021 |e 1 |b 07 |c 01 |h 168-180 |